Sarah FeldmanMD, MPH
Sarah Feldman M.D. M.P.H. is an Associate Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School where she is co-Director of Ambulatory Gynecologic Oncology and Director of the Center for Pre-Invasive Disease of the Lower Genital Tract at Brigham and Women’s Hospital and Dana Farber Cancer Institute. These sites are local, national and international referral centers for the evaluation and management of women with cervical, vaginal and vulvar precancers and HPV related disease.
Dr. Feldman oversees multiple research projects on cervical cancer prevention, including studies evaluating effective approaches to cervical cancer screening and management, in particular assessing the impact of recent guidelines and changes in care and their impact on cervical cancer prevalence. She has written multiple editorials for the New England Journal and JAMA Internal Medicine, as well as other journals on screening for cervical cancer that explains new screening guidelines and examines the supporting evidence.